Login / Signup
Overall survival in first-line HR+/HER2- advanced breast cancer in the era of CDK4/6 inhibitors.
Rodrigo Sánchez-Bayona
Mafalda Oliveira
Published in:
Annals of oncology : official journal of the European Society for Medical Oncology (2024)
Keyphrases
</>
cell cycle
free survival
young adults